• Latest Posts
Sponsored by 12 Jul 2022

The organoid era: bringing patient-relevant preclinical models to the lab

Interview 12 Jul 2022

Where AI can’t go: PhoreMost’s quest to unearth protein degradation targets

Endogena Therapeutics to start clinical stage with treatment for blindness caused by retinitis pigmentosa

Financing round of $21M completed for drug to treat autoimmune diseases

Treatment for cancer-associated thrombosis fast-tracked by FDA

Opinion 11 Jul 2022

Precision medicine: the next big leap for metabolic disorders

ADVERTISEMENT

Study results reveal bleeding episodes are significantly reduced by hemophilia drug

New drug application for treatment of dry eyes disease submitted to FDA

Cancer therapeutics company’s double win with $25M funding, and appointment of new board member

Biosyntia closes a €11.5M round to launch world’s first bio-based vitamin B7

Biotech food colorant startup Phytolon seals $14.5M in funding

More News! 8 Jul 2022

Beyond Biotech podcast 4: CorePath, Rensselaer, Versameb

ADVERTISEMENT